Please wait...
GulfBase Live Support
Leave a message and our representative will contact you soon
- TAQA Group reports Q1 revenue of $ 3.87bn, up 3.8%
- Bahrain All Share Index closes higher
- UAE airline Etihad places major aircraft order with Boeing
- UN forecasts global economic growth to drop to 2.4% in 2025
- Dubai gold rate shoots up after Dh10 plus drop - in hours
- Abraj Energy signs deal with BP for drilling rig in Block 61
- Commercial Bank launches new CB Corporate Banking App
- QSE sees 62% of stocks in the red; index loses 19 points
- Financial markets development essential to Qatar's comprehensive financial strategy: QCB Governor
- Emirates NBD pilots new AI compliance tech to reduce risks, improve payment speed
- AVALONPHARMA
- :129.8
- :126
- ('000):20,000
- ( '000):2,536,000
- :0
-
37,181 - :0
- :
- 12.31%
- 18.50%
-
623 -
():
4,734,571 - ():6,031,213
- :0.79
- Performance Comparison
- :Saudi Stock Exchange
- :Pharma, Biotech & Life Science
- :Small Cap
- :Health Care
Company Overview
- :29/06/1998
- :SAR 200,000,000
- :SAR 10
Activities
Middle East Pharmaceutical Industries Company is a prominent pharmaceutical company headquartered in Riyadh, Saudi Arabia. The company focuses on research, development, manufacturing, and marketing of generic medicines and pharmaceutical preparations. Their product portfolio includes treatments for various health conditions, such as: skin diseases, respiratory, central nervous, digestive, and musculoskeletal system disorders, urinary and reproductive system issues, diabetes, cardiovascular diseases, and anti-infective treatments, pain relief, antiseptics, and men's and women's health products. The company operates through three segments: Private, Public, and Export. Additionally, they offer contract manufacturing services and specialize in cosmetic, health products, and nutritional supplements. Formerly known as Middle East Chemical Products Factory Company, it changed its name to Middle East Pharmaceutical Industries Company in January 2006. The company also exports its products internationally, contributing to healthcare access beyond its home country.
-
Chairman:Ahmed S. A. Al-Tabbaa
-
Vice-chairman:Hisham M. M. Attar
-
CEO:Mohamed M. M. Al-Ghannam
-
General Manager:
-
Managing Director:
-
Board Members:
Faisal S. M. Al-Jaman
Mohammed M. Al-Ghannam
Omar M. S. Al-Jaroudi
-
Auditors:
KPMG Professional Consulting
CFO
| Announced On | Period | As Of | Net Profit (SAR Mil) | Growth (%) |
|---|---|---|---|---|
| 12/05/2025 | 3-Month | 31/03/2025 | 19 | 107.07 |
| 23/03/2025 | 12-Month | 31/12/2024 | 80 | 21.3 |
| 07/11/2024 | 9-Month | 30/09/2024 | 35 | 0 |
| 06/08/2024 | 6-Month | 30/06/2024 | 31 | 77.63 |
| 19/05/2024 | 3-Month | 31/03/2024 | 09 | 0 |
- investor.relations@avalon.com.sa
- www.avalonpharmaceutical.com
- P.O. Box 3800 Riyadh 14331
| Market Cap US$ Mil |
Last Price Local Cry |
Price Change (%) 1 Day |
Price Change (%) 1 Year |
P/E TTM | P/B MRQ | Dividend Yield (%) | Beta | ROA (%) | ROE (%) | |
|---|---|---|---|---|---|---|---|---|---|---|
| SULAIMANALHABIB | 25,184.25 | 268 | -0.75 | -2.58 | 42.44 | 0 | 0 | 0 | 0 | 0 |
| PUREHEALTH | 8,196.24 | 2.7 | -0.37 | 0 | 26.81 | 0 | 0 | 0 | 0 | 0 |
| ARMAH | 7,881.26 | 89.8 | -0.23 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| NAHDI | 4,219.76 | 122.2 | 0.32 | -15.6 | 19 | 0 | 0 | 0 | 0 | 0 |
| MOUWASAT | 4,136.08 | 76.7 | -1.16 | -28.46 | 23.58 | 2.79 | 0 | 0.81 | 13.85 | 22.49 |
| JAMJOOMPHARMA | 3,357.9 | 180 | 0 | 18.09 | 36.06 | 0 | 0 | 0 | 0 | 0 |
| DALLAHHEALTH | 3,087.39 | 117 | -1.35 | -5.63 | 24.6 | 4.31 | 0 | 0.93 | 12.1 | 17.53 |
| FAKEEHCARE | 2,865.73 | 46.5 | 0.32 | 0 | 39.94 | 0 | 0 | 0 | 0 | 0 |
| AME | 2,141.59 | 115.8 | 0.87 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CARE | 1,941.09 | 166.2 | 2.33 | -16.19 | 26.54 | 7.55 | 0 | 0.85 | -0.59 | -0.89 |
| NABAALSAHA | 1,922.4 | 67.2 | -2.19 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| TIBBIYAH | 1,700.27 | 31.9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SAUDIGERMANHEALTH | 1,569.83 | 63.3 | -1.1 | -28.25 | 27.87 | 3.61 | 0 | 0.79 | 11.92 | 18.76 |
| PROMEDEX | 892.64 | 95.7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SPIMACO | 863.46 | 26.9 | -0.38 | -2.21 | 80.02 | 1.23 | 0 | 0.91 | 8.47 | 15.11 |
| ALMUJTAMAMEDICAL | 784.84 | 32 | 3.22 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| AVALONPHARMA | 688.64 | 126.8 | -1.86 | 0 | 32.12 | 0 | 0 | 0 | 0 | 0 |
| MIRAL | 621.48 | 116.6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| MIDAN | 524.21 | 789 | 0 | -4.78 | 14.01 | 1.38 | 0 | 0 | 12.06 | 17.87 |
| QOMEL | 508.35 | 55 | 0.91 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| JULPHAR | 446.52 | 1.38 | -2.82 | 0 | -71.36 | 0.69 | 5.27 | 0.2 | 4.09 | 0 |
| AYYAN | 401.76 | 14.7 | -1.87 | -8.1 | -7.15 | 1.5 | 0 | 0.81 | -2 | -2.64 |
| GMPC | 393.81 | 2.14 | 3.38 | 0 | 0 | 1.1 | 3 | -0.08 | 75.81 | 111.42 |
| ATC.KW | 364.68 | 741 | 0 | 0 | 157.88 | 2.25 | 1.82 | -0.01 | 2.93 | 12.88 |
| MCGS | 346.4 | 4.64 | 2.65 | -0.04 | 21.18 | 0.13 | 5.86 | 0.98 | 6.76 | 7.99 |
| EQUIPMENTHOUSE | 324.2 | 39.9 | -1.61 | 5.1 | 25.3 | 0 | 0 | 0 | 0 | 0 |
| LANA | 287.82 | 30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| TMC | 229.4 | 22 | 2.23 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| RPM | 223.75 | 4.21 | 2.43 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| BURJEEL | 209.69 | 1.46 | -1.36 | 0 | 1.65 | 0 | 0 | 0 | 0 | 0 |
| CMCER | 143.64 | 6.93 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| ALMODAWAT | 113.8 | 18.12 | 0.77 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| FUTURECARE | 50.77 | 3.73 | -2.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| QGMD | 43.09 | 1.37 | 0 | 16.69 | -2.31 | 0.23 | 0 | 0.76 | -6.18 | 0 |
| SMILECARE | 30.65 | 5.72 | -0.53 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| BALSMMEDICAL | 25.65 | 77 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| ALRAZI | 17.09 | 42.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| JANA | 14.49 | 16.6 | -1.9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Financial Information Co.
P.O. Box 69410, Jeddah 11547, Saudi Arabia